FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: An FDA approval for Moderna's mRNA flu vaccine could influence vaccine availability and public health strategies within Michigan, as it would introduce a new type of flu vaccine to the market.

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.